vimarsana.com

By Josh Beckerman Femasys shares more than doubled Friday, reaching a 52-week high, after HC Wainwright raised its price target to $13 from $5. The stock was...

Related Keywords

Josh Beckerman ,Drug Administration ,Article Normal ,Medical Equipment Supplies ,Healthcare Life Sciences ,Medical Devices Apparatus ,Diagnostic Therapeutic Devices ,Synd ,Femasys ,Femy ,Medical Equipment ,Supplies ,Healthcare ,Life Sciences ,Medical Devices ,Apparatus ,Diagnostic ,Therapeutic Devices ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.